SEC Form 4 · accession 0001093557-16-000446
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance H Gregg
Officer — Executive Chairman · Director
Period of report
Mar 8, 2016
Accepted (ET)
Mar 10, 2016 · 8:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 8, 2016 | A | 34,000 | $0.001 | A | 493,018 | D | |
| Common Stock | holding | — | — | — | 11,461 | I | by IRA | |
| Common StockF3 | holding | — | — | — | 301,064 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that are exempt from Section 16 b-3 and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 100,017 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017, 60,938 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 5,079 unvested restricted stock units granted on March 11, 2013, which shall vest on March 11, 2016.
- F3Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.